2021
DOI: 10.1016/j.ejphar.2021.173930
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes

Abstract: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which emerged in December 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic, took the world by surprise with an unprecedented public health emergency. Since this pandemic began, extraordinary efforts have been made by scientists to understand the pathogenesis of COVID-19, and to fight the infection by providing various preventive, diagnostic and treatment opportunities based on either novel hypotheses or past experiences. Despite … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(24 citation statements)
references
References 146 publications
0
24
0
Order By: Relevance
“…Since the outbreak of the disease, various countries have reached the conclusion that the accurate, efficient, comprehensive, reliable, and up-to-date assessment of available information plays a vital role in the effective management of this incident (9). Although several therapeutic compounds and drugs have been recommended to overcome COVID-19, they are often considered supportive treatment options (10,11).…”
Section: Contextmentioning
confidence: 99%
“…Since the outbreak of the disease, various countries have reached the conclusion that the accurate, efficient, comprehensive, reliable, and up-to-date assessment of available information plays a vital role in the effective management of this incident (9). Although several therapeutic compounds and drugs have been recommended to overcome COVID-19, they are often considered supportive treatment options (10,11).…”
Section: Contextmentioning
confidence: 99%
“…The virus has rapidly spread across the world, resulting in a worldwide pandemic that has lasted through this moment [1]. Although many therapeutic compounds and drugs have been suggested and repurposed in the fight against COVID-19, they remained as supportive treatment options [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, nanomedicine is extensively acclaimed as potential probe agents in detecting and treating coronavirus 2 (SARS-CoV-2), MERS-CoV, ZIKA and other viral infections. These novel nanotherapeutics reduced inflammation and controlled fulminant cytokine storm when COVID-19 infections transpired [3]. The various immunological phases were identified by the decrease of CD 4+ , CD 8+ , T-lymphocytes (lymphopenia), and CD 4+ cell expression of INF-γ.…”
Section: Globalize Your Researchmentioning
confidence: 99%